[1] |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022, 43(7):561-632.
|
[2] |
Auffret V, Puri R, Urena M, et al. Conduction disturbances after transcatheter aortic valve replacement: current sta‐tus and future perspectives[J]. Circulation, 2017, 136(11):1049-1069.
|
[3] |
Costa G, Zappulla P, Barbanti M, et al. Pacemaker depen‐dency after transcatheter aortic valve implantation: inci‐dence, predictors and long-term outcomes[J]. EuroInter‐vention, 2019, 15(10):875-883.
|
[4] |
Metkus TS, Schulman SP, Marine JE, et al. Complications and outcomes of temporary transvenous pacing: an analy‐sis of > 360,000 patients from the national inpatient sam‐ple[J]. Chest, 2019, 155(4):749-757.
|
[5] |
何金山, 段江波, 李思聪, 等. 感染性心内膜炎患者电极拔除后采用主动固定电极连接体外永久起搏器进行过渡治疗的安全性探讨[J]. 中华心血管病杂志, 2022, 50(12):1214-1219.
|
[6] |
Moreno R, Dobarro D, López de Sá E, et al. Cause of com‐plete atrioventricular block after percutaneous aortic valve implantation: insights from a necropsy study[J]. Cir‐culation, 2009, 120(5):e29-e30.
|
[7] |
Rodés-Cabau J, Gutiérrez M, Bagur R, et al. Incidence, pre‐dictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve im‐plantation[J]. J Am Coll Cardiol, 2011, 57(20):1988-1999.
|
[8] |
Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchro‐nization therapy: the Task Force on cardiac pacing and re‐synchronization therapy of the European Society of Cardi‐ology (ESC). Developed in collaboration with the Europe‐an Heart Rhythm Association (EHRA) [J]. Eur Heart J,2013, 34(29):2281-2329.
|
[9] |
Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchroniza‐tion therapy[J]. Eur Heart J, 2021, 42(35):3427-3520.
|
[10] |
Junquera L, Freitas-Ferraz AB, Padrón R, et al. Intraproce‐dural high-degree atrioventricular block or complete heart block in transcatheter aortic valve replacement re‐cipients with no prior intraventricular conduction distur‐bances[J]. Catheter Cardiovasc Interv, 2020, 95(5):982-990.
|
[11] |
Rodés-Cabau J, Ellenbogen KA, Krahn AD, et al. Manage‐ment of conduction disturbances associated with trans‐catheter aortic valve replacement: JACC scientific expert panel[J]. J Am Coll Cardiol, 2019, 74(8):1086-1106.
|
[12] |
Lilly SM, Deshmukh AJ, Epstein AE, et al. 2020 ACC Expert consensus decision pathway on management of conduc‐tion disturbances in patients undergoing transcatheter aortic valve replacement: a report of the American Col‐lege of Cardiology Solution Set Oversight Committee[J]. J Am Coll Cardiol, 2020, 76(20):2391-2411.
|
[13] |
Goncalves CR, Bertog S, Tholakanahalli V, et al. Permanent pacemaker lead insertion connected to an external pace‐maker generator for temporary pacing after transcatheter aortic valve implantation[J]. Cardiovasc Revasc Med,2020, 21(6):726-729.
|
[14] |
Leong D, Sovari AA, Ehdaie A, et al. Permanent-temporary pacemakers in the management of patients with conduc‐tion abnormalities after transcatheter aortic valve re‐placement[J]. J Interv Card Electrophysiol, 2018, 52(1):111-116.
|
[15] |
Chang S, Liu X, Lu ZN, et al. Feasibility study of temporary permanent pacemaker in patients with conduction block after TAVR[J]. Front Cardiovasc Med, 2023, 10:978394.
|